{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:54:00Z","timestamp":1794513240601,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum des Saarlandes und Medizinische Fakult\u00e4t der Universit\u00e4t des Saarlandes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The ATP-binding cassette subfamily B member 4 (<jats:italic>ABCB4<\/jats:italic>) gene encodes the hepatic phospholipid transporter. Variants in the <jats:italic>ABCB4<\/jats:italic> gene are associated with various cholestatic phenotypes, some of which progress to liver fibrosis and cirrhosis. The aim of our study was to investigate the role of the cholestasis-associated variant <jats:italic>ABCB4<\/jats:italic> c.711A\u2009&gt;\u2009T (p.I237I, rs2109505) in patients with primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two cohorts of Polish patients took part in this study. The Szczecin cohort comprised 196 patients with PBC (174 females, 38% with cirrhosis) and 135 patients with PSC (39 females, 39% with cirrhosis). The Warsaw cohort consisted of 260 patients with PBC (241 females, 44% with cirrhosis) and 276 patients with PSC (97 females, 33% with cirrhosis). Two control cohorts\u2014150 healthy blood donors and 318 patients without liver disease, were recruited in Szczecin and in Warsaw, respectively. The <jats:italic>ABCB4<\/jats:italic>\u00a0c.711A\u2009&gt;\u2009T polymorphism was genotyped using TaqMan assay. In both PBC cohorts, carriers of the risk variant presented more frequently with cirrhosis (Szczecin: OR\u2009=\u20091.841, <jats:italic>P<\/jats:italic>\u2009=\u20090.025; Warsaw: OR\u2009=\u20091.528, <jats:italic>P<\/jats:italic>\u2009=\u20090.039). The risk allele was associated with increased serum AST, GGT and ALP (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) at inclusion. During the follow-up, patients in both cohorts significantly improved their laboratory results, independently of their <jats:italic>ABCB4<\/jats:italic>\u00a0c.711A\u2009&gt;\u2009T genotype (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). During 8\u2009\u00b1\u20094\u00a0years follow-up, a total of 22 patients in the Szczecin PBC group developed cirrhosis, and this risk was higher among carriers of the risk variant (OR\u2009=\u20095.65, <jats:italic>P<\/jats:italic>\u2009=\u20090.04). In contrast to PBC, we did not detect any association of <jats:italic>ABCB4<\/jats:italic>\u00a0c.711A\u2009&gt;\u2009T with a\u00a0liver phenotype in PSC cohorts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The frequent pro-cholestatic variant <jats:italic>ABCB4<\/jats:italic> c.711A\u2009&gt;\u2009T modulates liver injury in PBC, but not in PSC. In particular, carriers of the major allele are at increased risk of progressive liver scarring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02565-6","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T11:03:10Z","timestamp":1668682990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Beata","family":"Kruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Raszeja-Wyszomirska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-0777","authenticated-orcid":false,"given":"Marcin","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"2565_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","volume":"66","author":"GJ Webb","year":"2016","unstructured":"Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun. 2016;66:25\u201339.","journal-title":"J Autoimmun"},{"issue":"14","key":"2565_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJM199504063321406","volume":"332","author":"YM Lee","year":"1995","unstructured":"Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 1995;332(14):924\u201333.","journal-title":"N Engl J Med"},{"issue":"21","key":"2565_CR3","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335(21):1570\u201380.","journal-title":"N Engl J Med"},{"issue":"12","key":"2565_CR4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353(12):1261\u201373.","journal-title":"N Engl J Med"},{"issue":"6","key":"2565_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/gut.2003.023937","volume":"53","author":"MI Prince","year":"2004","unstructured":"Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut. 2004;53(6):865\u201370.","journal-title":"Gut"},{"issue":"4 Pt B","key":"2565_CR6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.bbadis.2017.07.029","volume":"1864","author":"MC Reichert","year":"2018","unstructured":"Reichert MC, Hall RA, Krawczyk M, Lammert F. Genetic determinants of cholangiopathies: molecular and systems genetics. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1484\u201390.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1 Suppl","key":"2565_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","volume":"32","author":"J Bosch","year":"2000","unstructured":"Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol. 2000;32(1 Suppl):141\u201356.","journal-title":"J Hepatol"},{"issue":"3","key":"2565_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","volume":"73","author":"AF Stattermayer","year":"2020","unstructured":"Stattermayer AF, Halilbasic E, Wrba F, Ferenci P, Trauner M. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. J Hepatol. 2020;73(3):651\u201363.","journal-title":"J Hepatol"},{"issue":"5","key":"2565_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","volume":"453","author":"RP Oude Elferink","year":"2007","unstructured":"Oude Elferink RP, Paulusma CC. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 2007;453(5):601\u201310.","journal-title":"Pflugers Arch"},{"issue":"2","key":"2565_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0168-8278(01)00125-8","volume":"35","author":"CP Nibbering","year":"2001","unstructured":"Nibbering CP, Groen AK, Ottenhoff R, Brouwers JF, vanBerge-Henegouwen GP, van Erpecum KJ. Regulation of biliary cholesterol secretion is independent of hepatocyte canalicular membrane lipid composition: a study in the diosgenin-fed rat model. J Hepatol. 2001;35(2):164\u20139.","journal-title":"J Hepatol"},{"issue":"4","key":"2565_CR11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/hep.22485","volume":"48","author":"D Gotthardt","year":"2008","unstructured":"Gotthardt D, Runz H, Keitel V, Fischer C, Flechtenmacher C, Wirtenberger M, et al. A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults. Hepatology. 2008;48(4):1157\u201366.","journal-title":"Hepatology"},{"issue":"1","key":"2565_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","volume":"135","author":"M Ziol","year":"2008","unstructured":"Ziol M, Barbu V, Rosmorduc O, Frassati-Biaggi A, Barget N, Hermelin B, et al. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults. Gastroenterology. 2008;135(1):131\u201341.","journal-title":"Gastroenterology"},{"issue":"5","key":"2565_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/liv.15200","volume":"42","author":"ED Pfister","year":"2022","unstructured":"Pfister ED, Droge C, Liebe R, Stalke A, Buhl N, Ballauff A, et al. Extrahepatic manifestations of progressive familial intrahepatic cholestasis syndromes: presentation of a case series and literature review. Liver Int. 2022;42(5):1084\u201396.","journal-title":"Liver Int"},{"issue":"5","key":"2565_CR14","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1136\/jmg.40.5.e70","volume":"40","author":"R Mullenbach","year":"2003","unstructured":"Mullenbach R, Linton KJ, Wiltshire S, Weerasekera N, Chambers J, Elias E, et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet. 2003;40(5):e70.","journal-title":"J Med Genet"},{"issue":"2","key":"2565_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/gut.2006.092742","volume":"56","author":"HE Wasmuth","year":"2007","unstructured":"Wasmuth HE, Glantz A, Keppeler H, Simon E, Bartz C, Rath W, et al. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut. 2007;56(2):265\u201370.","journal-title":"Gut"},{"issue":"5","key":"2565_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/ng.3247","volume":"47","author":"DF Gudbjartsson","year":"2015","unstructured":"Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015;47(5):435\u201344.","journal-title":"Nat Genet"},{"issue":"4","key":"2565_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1470-2045(17)30167-5","volume":"18","author":"S Mhatre","year":"2017","unstructured":"Mhatre S, Wang Z, Nagrani R, Badwe R, Chiplunkar S, Mittal B, et al. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study. Lancet Oncol. 2017;18(4):535\u201344.","journal-title":"Lancet Oncol"},{"issue":"12","key":"2565_CR18","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1111\/liv.14662","volume":"40","author":"E de Vries","year":"2020","unstructured":"de Vries E, Mazzetti M, Takkenberg B, Mostafavi N, Bikker H, Marzioni M, et al. Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma. Liver Int. 2020;40(12):3042\u201350.","journal-title":"Liver Int"},{"issue":"4","key":"2565_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0038-1667299","volume":"38","author":"MC Reichert","year":"2018","unstructured":"Reichert MC, Lammert F. ABCB4 gene aberrations in human liver disease: an evolving spectrum. Semin Liver Dis. 2018;38(4):299\u2013307.","journal-title":"Semin Liver Dis"},{"issue":"10","key":"2565_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","volume":"70","author":"PJ Trivedi","year":"2021","unstructured":"Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70(10):1989\u20132003.","journal-title":"Gut"},{"issue":"6","key":"2565_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","volume":"67","author":"C Droge","year":"2017","unstructured":"Droge C, Bonus M, Baumann U, Klindt C, Lainka E, Kathemann S, et al. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants. J Hepatol. 2017;67(6):1253\u201364.","journal-title":"J Hepatol"},{"issue":"5","key":"2565_CR22","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.28300","volume":"63","author":"JL Delaunay","year":"2016","unstructured":"Delaunay JL, Durand-Schneider AM, Dossier C, Falguieres T, Gautherot J, Davit-Spraul A, et al. A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3. Hepatology. 2016;63(5):1620\u201331.","journal-title":"Hepatology"},{"issue":"3","key":"2565_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/hep.22382","volume":"48","author":"Y Ohishi","year":"2008","unstructured":"Ohishi Y, Nakamura M, Iio N, Higa S, Inayoshi M, Aiba Y, et al. Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis. Hepatology. 2008;48(3):853\u201362.","journal-title":"Hepatology"},{"issue":"8","key":"2565_CR24","doi-asserted-by":"publisher","first-page":"e0202942","DOI":"10.1371\/journal.pone.0202942","volume":"13","author":"B Kruk","year":"2018","unstructured":"Kruk B, Liebe R, Milkiewicz M, Wunsch E, Raszeja-Wyszomirska J, Lammert F, et al. PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: a prospective analysis of 178 patients with PSC. PLoS ONE. 2018;13(8):e0202942.","journal-title":"PLoS ONE"},{"issue":"7","key":"2565_CR25","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2020.01.053","volume":"158","author":"M Krawczyk","year":"2020","unstructured":"Krawczyk M, Liebe R, Lammert F. Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and beyond. Gastroenterology. 2020;158(7):1865\u201380.","journal-title":"Gastroenterology"},{"issue":"6","key":"2565_CR26","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/liv.12730","volume":"35","author":"J Raszeja-Wyszomirska","year":"2015","unstructured":"Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Bogdanos D, Milkiewicz P. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis. Liver Int. 2015;35(6):1764\u201371.","journal-title":"Liver Int"},{"key":"2565_CR27","doi-asserted-by":"publisher","first-page":"30847","DOI":"10.1038\/srep30847","volume":"6","author":"E Wunsch","year":"2016","unstructured":"Wunsch E, Krawczyk M, Milkiewicz M, Trottier J, Barbier O, Neurath MF, et al. Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases. Sci Rep. 2016;6:30847.","journal-title":"Sci Rep"},{"issue":"1","key":"2565_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145\u201372.","journal-title":"J Hepatol"},{"issue":"3","key":"2565_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"European Association for the Study of the Liver","year":"2022","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022;77(3):761\u2013806.","journal-title":"J Hepatol"},{"issue":"2","key":"2565_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the Liver","year":"2009","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237\u201367.","journal-title":"J Hepatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02565-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02565-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02565-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T11:07:44Z","timestamp":1668683264000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02565-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2565"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02565-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Pomeranian Medical University (BN-001\/43\/06) and Medical University of Warsaw (KB\/58\/A\/2016), conformed to the Ethical Guidelines of the 1975 Declaration of Helsinki (6th revision, 2008).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Appropriate informed consent was obtained from each patient included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare any commercial or non-commercial conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}